-
Mashup Score: 1Best of Molecular Therapy 2020 - 3 year(s) ago
Best of Molecular Therapy 2020
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Molecular Therapy: Clinical gene therapy special issue - 3 year(s) ago
Molecular Therapy: Clinical gene therapy special issue
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
Extensive research and new technologies have contributed to the emergence of #GeneTherapy as a promising platform to treat many human diseases. Download the free special issue from @MolTherapy. #ASGCT21 https://t.co/BazTKYmD8R https://t.co/xmdg3bg6mq
-
-
Mashup Score: 0Cell Press Selection 2021: CRISPR for next-gen therapeutics - 3 year(s) ago
Cell Press Selection 2021: CRISPR for next-gen therapeutics
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
CRISPR technology has already entered the clinic and shown promise in #GeneTherapy applications for the treatment of #HumanDisease. Find out more in the Cell Press Selection. @ASGCTherapy #ASGCT21 https://t.co/ycZu7mHlq3 https://t.co/zXyMglV0MZ
-
-
Mashup Score: 0Best of Molecular Therapy 2020 - 3 year(s) ago
Best of Molecular Therapy 2020
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
Celebrate the exciting research published in @MolTherapy with this collection! Download the Best of Molecular Therapy Family of Journals 2020. #ASGCT21 https://t.co/aN2LnpRwPu https://t.co/8EB5cMIHrP
-
-
Mashup Score: 2Molecular Therapy: Clinical gene therapy special issue - 3 year(s) ago
Molecular Therapy: Clinical gene therapy special issue
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
Three decades of #ClinicalGeneTherapy: From experimental technologies to viable treatments. Download the free @MolTherapy special issue today. #ASGCT21 https://t.co/owqlo3VI38 https://t.co/GtRAXXvXge
-
-
Mashup Score: 4Molecular Therapy: Clinical gene therapy special issue - 3 year(s) ago
Molecular Therapy: Clinical gene therapy special issue
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
This special issue of @MolTherapy on the topic of #ClinicalGeneTherapy reviews the critical discoveries that led to the development of successful #GeneTherapies. #ASGCT21 https://t.co/CbkWwXj2HZ https://t.co/VEQsdpCbG2
-
-
Mashup Score: 3Off-the-Shelf Allogeneic Cell Therapy Shows Early Promise in Relapsed/Refractory CD30+ Lymphoma - 3 year(s) ago
An off-the-shelf, allogeneic CD30-CAR Epstein Barr virus–specific T-cell therapy has demonstrated favorable safety and encouraging clinical activity, even when given at lower dose levels, in patients with relapsed/refractory CD30-positive lymphoma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Off-the-Shelf Allogeneic Cell Therapy Shows Early Promise in Relapsed/Refractory CD30+ Lymphoma @ASGCTherapy #ASGCT21 #lymsm https://t.co/Ewx5n6NN8b
-
-
Mashup Score: 8Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy - 3 year(s) ago
Dr. Larry Corey is one of two winners of the American Society of Gene & Cell Therapy‘s Sonia Skarlatos Public Service Award, which recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy.
Source: Fred HutchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Congrats Dr. Larry Corey on receiving @ASGCTherapy‘s Sonia Skarlatos Public Service Award at #ASGCT21. Corey is recognized for contributions to the field of gene & cell therapy through his ongoing work with Fred Hutch, @PreventCOVID_19 and @HelpEndHIV. https://t.co/iqLaWhApC9
-
-
Mashup Score: 4
UCARTCS1A demonstrated early antitumor activity in heavily pretreated patients with relapsed/refractory multiple myeloma in whom previous CAR T-cell therapy and/or transplant had failed, according to preliminary data from the phase 1 MELANI-01 trial.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CAR T-Cell Therapy UCARTCS1A Shows Early Activity in Relapsed/Refractory Myeloma @MDAndersonNews @ASGCTherapy #ASGCT21 #mmsm https://t.co/l5H1G0nv9y
-
-
Mashup Score: 14The role of nanotechnology in current COVID-19 outbreak - 3 year(s) ago
COVID-19; Nanoparticle; Drug repurposing; Vaccine; Nanocarrier; Coronavirus; Drug delivery; Nanomaterials; Nanotechnology; Cells; Preclinical; Clinical.
Source: HeliyonCategories: General Medicine News, Latest HeadlinesTweet-
This review by Iran University of Medical Sciences, @Pharmidex, Kerman University of Medical Sciences and @nanoregmed discusses the role of non-toxic antiviral nanoparticles in the current COVID-19 outbreak. Learn more in @HeliyonJournal https://t.co/KrU0DdYOaU #ASGCT21 https://t.co/aUGesl0Nhu
-
Read popular papers published in @MolTherapy. Download the free Best of Molecular Therapy Family of Journals 2020. #ASGCT21 https://t.co/JOnrgqATl7 https://t.co/ktQJxiz7QV